Posts by: Margarida Azevedo

Margarida Azevedo

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

June 6, 2016June 6, 2016

#CMSC16 – MS Research Highlights How Sensory Processing, Fatigue, and Cognition Assessment May Improve Clinical Care

News

Melissa A. Colbeck, an investigator at the Occupational Therapy, Health Sciences Centre in Winnipeg, Canada, studied how different sensory processing approaches, cognition, and fatigue influence the quality ... Read more

June 6, 2016June 6, 2016

#CMSC16 – MS Care Should Include Fatigue, Sleep Quality and Inattentiveness Assessment, Study Shows

News

Mayis Al Dughmi, of the Physical Therapy and Rehabilitation Science at the University of Kansas Medical Center, recently presented her findings on the relationship between fatigue, ... Read more

June 6, 2016June 6, 2016

#CMSC16 – Researchers Present Findings Showing Women with MS Have Significant Depression, Fatigue, Decline in Cognitive Function

News

Researchers at the University of Arizona studied the psychosocial symptoms felt by a group of female patients with multiple sclerosis (MS) from the southwestern United States, ... Read more

June 1, 2016June 1, 2016

MS Research Australia Supporting Effort to Harness Anti-inflammatory Potential of Parasitic Worms

News

Researchers at the University of Technology Sydney (UTS) ithree institute are taking a novel approach in an attempt to halt disease progression in multiple sclerosis (MS). The scientists are planning to ... Read more

May 27, 2016May 27, 2016

Report Highlights Series of Changes Needed from Canadian Employers and Government to Improve MS Patients’ Lives

News

A new report by the Conference Board of Canada’s Canadian Alliance for Sustainable Health Care (CASHC) notes that employers and the Canadian government are not giving enough support towards increasing ... Read more

May 16, 2016May 16, 2016

Mitoxantrone, a Drug for Progressive and Severe Relapsing MS, Linked to Colorectal Cancer Risk

News

Mitoxantrone,  a multiple sclerosis (MS)  drug that is already associated with a higher risk for leukemia and heart damage, may also raise a person’s risk of colorectal cancer, researchers ... Read more

May 12, 2016May 12, 2016

United Spinal Association Offering Range of Materials at Exhibit Booth at CMSC 2016

News

The United Spinal Association, a nonprofit focused on improving the quality of life for people with spinal cord injuries and disorders (SCI/D), a group of conditions that include multiple ... Read more

May 6, 2016May 6, 2016

Celebrate Vision Health Month by Getting Your Eyes Examined, Optometrist Group Says

News

The Canadian Association of Optometrists is urging people to have their eyes examined regularly as a part of their preventive care routine. The plea, an education initiative for ... Read more

May 3, 2016May 3, 2016

Opexa’s CEO Gives Update on T-Cell Therapy at Vatican Conference

News

Opexa Therapeutics, Inc., announced that its president and chief executive officer, Neil K. Warma, recently gave a presentation on immunotherapy and its potential for treating autoimmune disorders, including multiple sclerosis, ... Read more

April 22, 2016April 22, 2016

Florida Atlantic University Researcher Awarded $540K NIH Grant to Research Collagen Degradation in Diseases Like MS

News

A researcher at Florida Atlantic University (FAU) has been awarded a $540,250 grant from the National Cancer Institute, part of the National Institutes of Health, to support continued ... Read more

April 21, 2016April 21, 2016

Mayo Clinic Neurologist, Creator of MS Lesion Tissue Bank, Receives 2016 John Dystel Prize for MS Research

News

Dr. Claudia Lucchinetti, chair of the Department of Neurology at the Mayo Clinic and the Eugene and Marcia Applebaum Professor of Neurosciences, has received the 2016 John ... Read more

April 20, 2016April 20, 2016

Sanofi Genzyme Presenting New Data on Lemtrada’s Beneficial Effects, Drawn from RRMS Extension Study, at AAN 2016

News

Sanofi Genzyme is presenting promising data regarding brain volume and retinal nerve fibers in multiple sclerosis (MS) patients — drawn from an ongoing extension study into the disease-modifying ... Read more

April 19, 2016April 19, 2016

Promising Phase 1 Trial Results of Stem Cell Therapy in Progressive MS Patients Being Presented at AAN Meeting

News

Potentially groundbreaking research by the Tisch Multiple Sclerosis Research Center of New York (MSRCNY) will be presented on April 19 at the 68th American Academy of Neurology (AAN) Annual ... Read more

April 19, 2016April 19, 2016

Antihistamine Aids in Reversing Visual Damage in MS Patients and Appears to Have Remyelination Properties, AAN Presentation Reports

News

A Phase 2 clinical trial testing the efficacy of a common antihistamine, clemastine fumarate, to treat optic nerve damage in people with multiple sclerosis (MS) found the drug ... Read more

April 11, 2016April 11, 2016

PathMaker Launches Clinical Trial of MyoRegulator to Treat Spasticity, Common in MS

News

PathMaker Neurosystems, Inc., recently announced the launch of an Institutional Review Board (IRB)-approved clinical trial, in partnership with Northwell Health (formerly North Shore-LIJ Health System) and The Feinstein Institute for ... Read more

April 4, 2016April 4, 2016

Experimental MS Oral Antibiotic Combination Therapy Showing Promise in Phase 2a Study, RedHill Biopharma Reports

News

RedHill Biopharma, Ltd. recently announced promising interim results from its ongoing CEASE-MS Phase 2a clinical trial evaluating the safety and efficacy of a fixed dose of RHB-104 as ... Read more

March 30, 2016March 30, 2016

Oral MS Drug Derived from Plant Peptide Seen to Stop Disease Progression in Mice

News

Researchers, working with an animal model of multiple sclerosis (MS), discovered that oral treatment with a synthesized plant peptide, known as cyclotide, halted the progression of ... Read more

March 22, 2016March 22, 2016

MS Patients Being Recruited for At-Home Study of Bacteria’s Benefits on Bladder Health

News

The United Spinal Association, a nonprofit focused on improving the quality of life of people with spinal cord injuries and disorders (SCI/D), a group of conditions that include ... Read more

March 21, 2016March 21, 2016

CONy16: MS Researchers Question Possible Long-term Benefits of Remyelination Therapies

News

Multiple sclerosis was a main focus at the four-day 10th World Congress on Controversies in Neurology (CONy), in Lisbon, Portugal, that concluded on March 20. Among the topics of ... Read more

March 18, 2016March 18, 2016

Resistance Training in Ms Patients Found to Improve Hip Strength, Walking Ability

News

Researchers at the Kennedy Krieger Institute and Johns Hopkins University School of Medicine released preliminary results of an ongoing study into an effective and progressive resistance training program ... Read more

March 17, 2016March 17, 2016

MS Research Australia Funds Projects into Targeted Gene Suppression, Drug Delivery

News

Professor Steve Wilton and Dr. Rakesh Veedu from Murdoch University’s Centre for Comparative Genomics in Western Australia received project grants of $50,000 and $25,000, respectively, to investigate ... Read more

March 15, 2016March 15, 2016

New MS Survey Looks into Patients’ Appraisal of Risks, Benefits When Choosing Therapies

News

A large-scale online survey, funded by the National Multiple Sclerosis Society  and developed by researchers, is investigating how multiple sclerosis (MS) patients perceive and evaluate the risks ... Read more

March 14, 2016March 14, 2016

Kinase Inhibitor, Masitinib, Spotted for Potential to Treat Neurological Disorders Like PPMS

News

AB Science recently reported the publication of four peer-reviewed and independent research papers that add to the growing recognition of masitinib, the company’s lead compound, as a ... Read more

March 11, 2016March 11, 2016

MS Society Honors MS Awareness Week with New ‘Together We Are Stronger’ Campaign

News

The National Multiple Sclerosis Society launched a new awareness campaign for Multiple Sclerosis Awareness Week, which runs through March 13, featuring the stories of people impacted by MS ... Read more

March 7, 2016March 7, 2016

Progressive MS Clinical Trial of Rituximab Stopped After Drug Fails to Show Effectiveness

News

Researchers at the National Institutes of Health (NIH) announced that a small clinical trial of a progressive multiple sclerosis (MS) treatment was stopped early due to poor ... Read more

March 2, 2016March 2, 2016

Therapeutic Target for Stabilizing Histamine, an Inflammatory Agent in MS, Identified in Fruit Fly Study

News

Researchers at the University of Massachusetts Medical School, working in the fruit fly model, identified an organic cation transporter, CarT (carcinine transporter), that is crucial to the recycling ... Read more

February 29, 2016February 29, 2016

MS Gait Analysis Identifies 2 New and Highly Sensitive Markers of Disability and Fatigue

News

Researchers analyzing gait in people with multiple sclerosis (MS) using wearable inertial sensors have established two new and highly sensitive observer-independent measures of disability that strongly correlate with fatigue and ... Read more

February 26, 2016February 26, 2016

MS Researchers Create a Nanoparticle Drug Able to Stop Inflammation and Autoimmune Attacks in Mice

News

Researchers, working on an animal model and human cells, discovered a mechanism to halt autoimmune disease damage and developed of a novel class of drugs that triggers ... Read more

February 25, 2016February 25, 2016

Biogen’s ‘1MSg Campaign’ Encourages MS Patients to Better Manage Their Disease, Engage with Specialists

News

Biogen is launching an initiative developed with the assistance of clinical experts — the 1MSg campaign — to educate and encourage multiple sclerosis (MS) patients to make disease management ... Read more

February 19, 2016February 19, 2016

Research on Progressive MS to Be Funded by International Progressive MS Alliance

News

Dr. Timothy Coetzee from the National Multiple Sclerosis Society will present an overview of the objectives and achievements of the International Progressive MS Alliance (PMSA), an ... Read more

February 19, 2016February 19, 2016

ACTRIMS 2016 Talk Weighs Clinical Differences, Similarities in 2 Major Forms of MS

News

Dr. Wayne Moore, from the University of British Columbia and the Vancouver General Hospital, will present an overview and analysis of the major histology and pathology ... Read more

February 18, 2016February 19, 2016

Effects of Specific Antibodies on MS Neurodegeneration to Be Presented at ACTRIMS Forum

News

Researchers from the University of Tennessee Health Science Center plan to present the results of a study investigating the contribution of specific antibodies to the neurodegeneration and neuronal ... Read more

February 18, 2016February 19, 2016

NIH Study into Progressive MS Biomarkers to Be Presented at ACTRIMS 2016

News

Scientists from the Neuroimmunological Diseases Unit at the National Institutes of Health (NIH) will present results of a study investigating several biomarkers that might lead to a more sensitive ... Read more

February 18, 2016February 19, 2016

Anavex Life Sciences to Present Preclinical Data on Lead MS Drug Candidate at ACTRIMS 2016

News

Anavex Life Sciences Corp., a biopharmaceutical company focused on the development of new therapies for neurodegenerative and central nervous system (CNS) diseases, among others, recently announced ... Read more

February 12, 2016February 12, 2016

RedHill’s Experimental MS Therapy, RHB-104, Receives Notice of Allowance on U.S. Patent

News

RedHill Biopharma, Ltd., an Israeli biopharmaceutical company focused on the development and commercialization of oral-administered small-molecule medicines for the treatment of inflammatory and gastrointestinal diseases, recently ... Read more

February 9, 2016February 9, 2016

MS Patients’ Diminished Sense of Taste Linked in Study to Severity of Brain Lesions

News

Taste deficits are considerably more prevalent in multiple sclerosis (MS) patients than previously thought, and correlate directly with the severity of MS-related brain lesions, researchers report ... Read more

February 8, 2016February 8, 2016

Experimental RRMS Therapy, Trimesta, Fails to Demonstrate Efficacy in Review of Clinical Trial

News

Synthetic Biologics, Inc., a clinical stage company focused on the development of therapeutics to protect the microbiome and to target disease-causing pathogens, recently announced disappointing results ... Read more

February 5, 2016February 5, 2016

MS-related Inflammation May Be Reduced With Natural Protein, Study Shows

News

In a new study using several mouse models of human immune-mediated inflammatory diseases, including multiple sclerosis (MS), researchers found that increased levels of an endogenous protein ... Read more

February 4, 2016March 4, 2016

Experimental MS Therapy Seen to Promote Myelin Regeneration in Preclinical Study

News

RegeneRx Biopharmaceuticals, Inc., announced the publication of a research article detailing the process by which Thymosin beta 4 (Tβ4), the company’s novel therapeutic peptide, effectively promoted the remyelination ... Read more

February 2, 2016February 2, 2016

Multiple Sclerosis Lesions Quickly Detected with New MRI Technique

News

Researchers developed a new way of using MRI (magnetic resonance imaging) to better distinguish multiple sclerosis (MS)-related “white spots” from similar brain lesions that corresponding to other ... Read more